PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
|Webcasts|October 29, 2019
Data Integrity and the Next Level of Connectivity in a Modern Lab
Author(s)Sartorius
Why is laboratory data integrity a hot topic for bio/pharma companies and regulators? Get insights on challenges and solutions in the paperless laboratory in this webcast. Live: Tuesday, Oct. 29, 2019 at 11am EDT | 8am PDT| 3pm GMT| 4pm CET On demand available after airing until Oct. 29, 2020 Register free
Register free:
Event Overview:
The digital transformation of laboratories brings many advantages but also new challenges for the laboratory staff. Ensuring the integrity of data and the seamless integration of laboratory instruments into the IT landscape are two major challenges. Join this webcast to learn how to fulfill data integrity in the paperless lab with an intelligent instrument design.
Key Learning Objectives:
Review why data integrity has become a hot topic in laboratories
Understand the problems to integrate instruments into a laboratory environment
Learn what is needed to document instrument results paperless under the aspects of data integrity
Speaker: Sebastian Weber, Product Manager Software Solutions, Sartorius
Time and Date: Tuesday, Oct. 29, 2019 at 11am EDT | 8am PDT | 3pm GMT | 4pm CET
On demand available after airing until Oct. 29, 2020
Sponsor: Sartorius
Register free:
Related to this article
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.